Neurosense Therapeutics Stock Forecast - Price Action Indicator
| NRSN Stock | USD 0.96 0.02 2.13% |
Neurosense Stock outlook is based on your current time horizon. Although Neurosense Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Neurosense Therapeutics' systematic risk associated with finding meaningful patterns of Neurosense Therapeutics fundamentals over time.
As of today, the RSI of Neurosense Therapeutics' share price is approaching 49. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Neurosense Therapeutics, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
EPS Estimate Current Year (0.40) | EPS Estimate Next Year (0.18) | Wall Street Target Price 11.5 |
Using Neurosense Therapeutics hype-based prediction, you can estimate the value of Neurosense Therapeutics from the perspective of Neurosense Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Neurosense Therapeutics after-hype prediction price | USD 0.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neurosense | Build AI portfolio with Neurosense Stock |
Neurosense Therapeutics Additional Predictive Modules
Most predictive techniques to examine Neurosense price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neurosense using various technical indicators. When you analyze Neurosense charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Neurosense Therapeutics Volatility | Backtest Neurosense Therapeutics | Information Ratio |
Neurosense Therapeutics Trading Date Momentum
| On January 26 2026 Neurosense Therapeutics was traded for 0.96 at the closing time. The top price for the day was 0.97 and the lowest listed price was 0.93 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not cause price change. The trading delta at closing time against the current closing price is 2.08% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Neurosense Therapeutics to competition |
Other Forecasting Options for Neurosense Therapeutics
For every potential investor in Neurosense, whether a beginner or expert, Neurosense Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neurosense Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neurosense. Basic forecasting techniques help filter out the noise by identifying Neurosense Therapeutics' price trends.Neurosense Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurosense Therapeutics stock to make a market-neutral strategy. Peer analysis of Neurosense Therapeutics could also be used in its relative valuation, which is a method of valuing Neurosense Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neurosense Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Neurosense Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurosense Therapeutics shares will generate the highest return on investment. By undertsting and applying Neurosense Therapeutics stock market strength indicators, traders can identify Neurosense Therapeutics entry and exit signals to maximize returns.
Neurosense Therapeutics Risk Indicators
The analysis of Neurosense Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurosense Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurosense stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.49 | |||
| Standard Deviation | 6.13 | |||
| Variance | 37.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Neurosense Therapeutics
The number of cover stories for Neurosense Therapeutics depends on current market conditions and Neurosense Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neurosense Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neurosense Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Neurosense Therapeutics Short Properties
Neurosense Therapeutics' future price predictability will typically decrease when Neurosense Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neurosense Therapeutics often depends not only on the future outlook of the potential Neurosense Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neurosense Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.6 M | |
| Cash And Short Term Investments | 3.4 M |
Check out Historical Fundamental Analysis of Neurosense Therapeutics to cross-verify your projections. To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.